In newly diagnosed grade 3 gliomas, the descending frequency of expression was A2aR > PD-1 > CD39 > CD73 > TIGIT > LAG-3 > BLTA > CD160 > CTLA-4 > KIR > TIM3 on CD8+ T cells. Here, CD160 is linked to central nervous system cancer.